Abstract:Objective To evaluate the feasibility of de tecting epidermal growth factor receptor (EGFR) mRNA by reverse transcription po lymerase chain reaction(RT-PCR)in peripheral blood of patients with breast cance r and to explore its significance. Methods RT-PCR assay w as applied to detect the expression of EGFR mRNA in the peripheral blood of 40 p atients with breast cancer and in 30 healthy donors. The result of EGFR mRNA was compared with that of known marker of circulating epithelial cells:CK-19. Results In peripheral blood from 30 healthy donors,none of EGF R mRNA was detected,but the positivity of CK19 mRNA expression was 26.7% (8/ 30) .In contrast ,EGFR mRNA was detected in 13 of 40(32.5%)patients with breast canc er,compared with healthy donors (P0.01),there was significant d ifference between the two groups. CK-19 mRNA was found in 14 of 40(35.0%), compa red with healthy donors (P0.05) and there was no statistical di fference. On the other hand, the expression of EGFR was observed in 25(62.5%) of tumor tissues by immunohistochemistry. We found that all patients who expressed EGFR mRNA in peripheral blood were also expressing EGFR in primary tumors. Pati ents with a high expression of EGFR in tumoral breast tissues display high expre ssion of EGFR in peripheral blood as well(P0.01). EGFR mRNA w as expressed in 5 of 26(19.2%) breast cancer patients without any treatments bef ore, but the positivity for EGFR mRNA expression was 57.1% (8/ 14) in breast can cer patients who have received treatments before. There is significant differenc e between two groups above (P0.05). Expression of EGFR mRNA was detected in 1of 6 (16.7%) metastatic breast cancer patients who have received P aclitaxel involved salvage chemotherapy, however, the positivity for EGFR mRNA e xpression was 87.5% (7/ 8) in them who have never received Paclitaxel contained salvage chemotherapy, there was significant difference between two groups ( P0.05). Conclusion CK-19 mR NA showed no dia gnostic value as marker of circulating tumor cells in breast cancers. However, E GFR mRNA in blood may be a useful marker of circulating tumor cells in breast ca ncers. Detecting EGFR mRNA in peripheral blood of patients with breast cancer us ing RT-PCR can be used as a prognostic indicator. Paclitaxel may reduce the risk of relapse and metastasis of breast cancer.

Genetic detection of lymph node micrometastases in colorectal cancer

Detection of Micrometastases in the Axillary Lymph Nodes in Patients with Breast Cancer by Reverse Transcriptase Polymerase Chain Reaction and Southern Hybridization

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF CYTOKERATIN 20 mRNA IN CENTRAL VEIN BLOOD OF PATIENTS WITH GASTRIC CANCER BY RT-PCR

Detection of K19 Mrna Expression for Diagnosis of Regional Lymph Nodes Micmmetastasis in Rectal Cancer Patients by Reverse Transcriptase Polymerase Chain Reaction

Detection and quantitation of CK19 mRNA in the peripheral blood and regional lymph nodes of lung cancer patients

Combined Detection of Breast Cancer Micrometastases in the Lymph Nodes and Bone Marrow Using Reverse-Transcriptase Chain Reaction and Southern Hybridization

Detection of Micrometastases of Non-small Cell Lung Cancer by Using CK19 mRNA and LUNX mRNASpecific Reverse Transcription-polymerase Chain Reaction

The Detection and Its Clinical Significance of Cytokeratin 19 Mrna (CK19 Mrna) in Pelvic Lymph Nodes of Cervical Cancer Patients

Detection of CK19mRNA in the Peripheral Blood of Lung Cancer Patients by Fluorogenic Quantitative Reverse Transcripition-Polymerase Chain Reaction

Priliminary Study of Sentinel Lymph Node Biopsy in Colorectal Cancer and Detection of Micrometastasis in Sentinel Lymph Node

Micrometastases Detected by Cytokeratin 19 Expression in Sentinel Lymph Nodes of Patients with Early-Stage Cervical Cancer

Clinical Study of Sentinel Lymph Node Biopsy in Colon Cancer

Inhibitory influence from the nucleus reticularis pontis oralis on the micturition reflex induced by electrical stimulation of the pontine micturition center in cats

Detection of Occult Carcinomatous Diffusion in Lymph Nodes from Laryngeal Squamous Cell Carcinoma

Comparative Study for Detecting Metastasis of Lymph Nodes of Lung Cancer Using CT, Pathology and CK19RT-PCR

Detection of micrometastatic cancer cells in peritoneal cavity of patients with colorectal cancer

Detection of Micrometastases of Lung Cancer by Using Lunx Mrna Specific Reverse Transcription-Polymerase Chain Reaction

Verification of a Molecular Pathology Detection Method of Sentinel Lymph Node in Breast Cancer Patients:A Comparison Between RT-LAMP and GeneSearch

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Comparative Study of Detection of Epidermal Growth Factor Receptor and Cytokeratin - 19 Mrna in Peripheral Blood of Breast Cancer Patients by Reverse Transcription Polymerase Chain Reaction

Significance of CK20 Mrna Expression in Peripheral Blood of Colorectal Cancer Patients by Real-Time Fluorescent Quantitative RT-PCR